The Patent Finder

Urocor, Inc.

Also on record
Records under this name other than patents Urocor, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Urocor, Inc.

PatentTitleStatus Expires Confidence
US 6,171,796Biomarkers and targets for diagnosis prognosis and management of prostate disease
Formerly held
Term ended
Term ended Aug 3, 2019 · From the USPTO record
Term endedTerm ended Aug 3, 2019From the USPTO record
US 6,156,515Prostate-specific gene for diagnosis, prognosis and management of prostate cancer
Formerly held
Term ended
Term ended Feb 9, 2019 · From the USPTO record
Term endedTerm ended Feb 9, 2019From the USPTO record
US 6,218,529Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer
Formerly held
Term ended
Term ended Jun 12, 2018 · From the USPTO record
Term endedTerm ended Jun 12, 2018From the USPTO record
US 6,190,857Diagnosis of disease state using MRNA profiles in peripheral leukocytes
Formerly held
Term ended
Term ended Mar 24, 2018 · From the USPTO record
Term endedTerm ended Mar 24, 2018From the USPTO record
US 6,025,128Prediction of prostate cancer progression by analysis of selected predictive parameters
Formerly held
Term ended
Term ended Feb 15, 2017 · From the USPTO record
Term endedTerm ended Feb 15, 2017From the USPTO record
US 7,332,270Diagnosis of disease state using mRNA profiles in peripheral leukocytes
Formerly held
Lapsed on the fee record
Ended Feb 19, 2016 · From the USPTO record
Lapsed on the fee recordEnded Feb 19, 2016From the USPTO record
US 7,993,830Prostate-specific gene for diagnosis, prognosis and management of prostate cancer
Formerly held
Lapsed on the fee record
Ended Aug 9, 2015 · From the USPTO record
Lapsed on the fee recordEnded Aug 9, 2015From the USPTO record
US 6,463,438Neural network for cell image analysis for identification of abnormal cells
Formerly held
Lapsed on the fee record
Ended Oct 8, 2014 · From the USPTO record
Lapsed on the fee recordEnded Oct 8, 2014From the USPTO record
US 6,369,195Prostate-specific gene for diagnosis, prognosis and management of prostate cancer
Formerly held
Lapsed on the fee record
Ended Apr 9, 2014 · From the USPTO record
Lapsed on the fee recordEnded Apr 9, 2014From the USPTO record
US 6,090,559Biomarkers for the detection of prostate cancer
Lapsed on the fee record
Ended Jul 18, 2004 · From the USPTO record
Lapsed on the fee recordEnded Jul 18, 2004From the USPTO record
10 of 15 patents shown.
Pro members see all 15.
Pro members: see all 15 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited